Michel Farnier

Université de Bourgogne — France

Medicine · Health Sciences

51h-index13.8kcitations382works2.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lipoproteins and Cardiovascular Health(285), Diabetes, Cardiovascular Risks, and Lipoproteins(91), Cancer, Lipids, and Metabolism(83), Pharmaceutical Economics and Policy(66), Health Systems, Economic Evaluations, Quality of Life(55)

Publications374 total

Higher eicosapentaenoic acid levels and eicosapentaenoic acid/docosahexaenoic acid ratios are associated with lower cardiovascular mortality post-myocardial infarction
European Journal of Preventive Cardiology·2025Open Access
Optimizing oral low-density lipoprotein cholesterol-lowering therapy in statin-intolerant patients: A simulation study in France
Archives of cardiovascular diseases·2025Open Access
High adherence to high-intensity statins after acute myocardial infarction: the ‘PACMAN pathway’
European Journal of Preventive Cardiology·2025
Lipid-lowering therapy use and LDL-C goal attainment in France: Results from 1-year follow-up of the European observational Santorini study
Atherosclerosis·2024Open Access
Long-term efficacy of evinacumab and improved cardiovascular outcome in patients with homozygous familial hypercholesterolaemia
Atherosclerosis·2024Open Access
Identification and characterisation of patients with statin intolerance in France
Atherosclerosis·2024Open Access
Risk factors and prognostic value of endotoxemia in patients with acute myocardial infarction
Frontiers in Cardiovascular Medicine·2024· 1 citedOpen Access
Evinacumab and Cardiovascular Outcome in Patients With Homozygous Familial Hypercholesterolemia
Arteriosclerosis Thrombosis and Vascular Biology·2024· 20 citedOpen Access
Management of lipid variables in primary cardiovascular prevention: A position paper from the Heart, Vessels and Metabolism Group of the French Society of Cardiology
Archives of cardiovascular diseases·2024· 1 cited
Negative relationship between eicosapentaenoic acid and inflammatory biomarkers in patients with acute myocardial infarction
Cardiovascular Research·2024· 5 cited
Is there still a place for fenofibrate-statin combination therapy?
European Atherosclerosis Journal·2023· 2 citedOpen Access
Characteristics and prognosis of patients with elevated triglycerides in acute myocardial infarction: observational data from a large database over a 17-year period
Journal of clinical lipidology·2023· 4 citedOpen Access
Non-HDL-cholesterol in dyslipidemia: Review of the state-of-the-art literature and outlook
Atherosclerosis·2023· 142 citedOpen Access
Characteristics and prognosis of patients with elevated triglycerides in acute myocardial infarction: observational data from a large database over a 17 years period
European Journal of Preventive Cardiology·2023Open Access
Effect of lipoprotein(a) levels on coronary lesion complexity in patients with acute myocardial infarction: data from the French RICO survey
European Journal of Preventive Cardiology·2023· 2 citedOpen Access
Evaluation of hypercholesterolemia management in at-risk patients by cardiologists in France: a case vignette-based study
Journal of Comparative Effectiveness Research·2023Open Access
Bempedoic acid in the management of lipid disorders and cardiovascular risk. 2023 position paper of the International Lipid Expert Panel (ILEP)
Progress in Cardiovascular Diseases·2023· 66 citedOpen Access
Evaluation of lipoprotein(a) in the prevention and management of atherosclerotic cardiovascular disease: A survey among the Lipid Clinics Network
Atherosclerosis·2023· 26 citedOpen Access
Lipid-lowering efficacy and safety of alirocumab in a real-life setting in France: Insights from the ODYSSEY APPRISE study
Archives of cardiovascular diseases·2022· 4 citedOpen Access
EPH37 High Cardiovascular Disease Risk and Low Lipid-Lowering Treatment in Heterozygous Familial Hypercholesterolemia Patients: A French Nationwide Registry
Value in Health·2022Open Access
page 1 of 19Next →

Frequent Co-authors

Michel Krempf(11), Éric Bruckert(8), Lâle Tokgözoğlu(8), G. Kees Hovingh(7), Bertrand Cariou(7), Jean‐Pierre Rabès(6), John J.P. Kastelein(6), Alberico L. Catapano(6), Alberto Zambon(6), Jennifer G. Robinson(5), Maurizio Averna(5), Gisle Langslet(5), Henry N. Ginsberg(5), Marie T. Baccara‐Dinet(5), Maciej Banach(5), Peter P. Tóth(5), Kausik K. Ray(5), Michal Vráblík(5), Alain Carrié(5), Jean Ferrières(5)